News

29 Nov 2011

The medtech company Likvor AB strengthens its competences with a new chairman of the board, Stefan Sallerfors. Sallerfors has a background as doctor and specialist in medical radiology and has been CEO for GE Medical System Sverige AB and Helsingborg hospital. In November Likvor continues the expansion on the European market with a new distribution agreement for the German market. The unique Likvor CELDA® System is therefore available in Germany, Austria and Switzerland through the new distributor, Neuromed. The system helps to restore normal life back to millions of dementia patients with hydrocephalus diagnosis.

10 Oct 2011

The unique Likvor CELDA® System is now available on the UK market and the first system has been sent to a customer. In addition, Likvor AB has signed a distribution agreement with its first distributor for this region. The system helps to restore normal life back to millions of dementia patients with hydrocephalus diagnosis.

29 Jun 2011

Likvor will appear at the 2011 meeting of the International Society for Hydrocephalus and CSF Disorders in Copenhagen. Likvor will be demonstrating the Likvor CELDA® System and answering any questions regarding the product. Likvor is at present focusing on expanding the international and global sales network with potential business partners for the Likvor CELDA® System.

10 Jun 2011

Likvor AB moves towards the international market for treatable dementia with a new CEO and a fresh injection of capital.

18 May 2011

Likvor AB is pleased to announce the appointment of Dr. Hadi Ghane, as Sales Director for our team. As "Sales Director", Dr. Ghane will be responsible for the sales activities of Likvor's current product portfolio, Likvor CELDA® System. Dr. Ghane will be a valuable contributor to and be an active part in the team to build up and prepare the company for future growth and expansion.

8 Feb 2011

Likvor has delivered its first Likvor CELDA® System to Kuopio University Hospital in Finland.

17 Jan 2011

Kuopio University Hospital increase their possibility to diagnose and treat Normal Pressure Hyrocephalus (NPH). Likvor has delivered its first Likvor CELDA® System to Kuopio University Hospital in Finland. The system will be installed at the department of Neurosurgery.